Reversible sulfasalazine-induced granulomatous hepatitis.
Sulfasalazine, a drug common in the treatment of inflammatory bowel disease, may cause liver damage. We present a patient with documented granulomatous hepatitis which resolved on liver biopsy 6 weeks after discontinuation of the drug.